Get App
Download App Scanner
Scan to Download
Advertisement

Privi Speciality in Focus: Motilal Oswal Remains Bullish on Strong Growth Story — Check Target Price

According to the brokerage Privi Speciality is well-positioned for sustainable growth, supported by its relatively low crude-linked exposure, which provides resilience against ongoing energy market volatility and supports margin stability.

Privi Speciality in Focus: Motilal Oswal Remains Bullish on Strong Growth Story — Check Target Price
The upcoming mergers with Privi Fine Science, Privi BiotechnologiesL and PRIGIV JV with Givaudaare expected to expand Privi's specialty aroma portfolio, which is expected to drive revenue growth, enhance earnings.
(Photo: NDTV Profit/ AI generated image)
STOCKS IN THIS STORY
Fairchem Speciality Ltd.
--

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

The brokerage firm Motilal Oswal Financial Services has reiterated its Buy rating on Privi Speciality Chemicals Ltd. with a target price of Rs 3900, based on 27x FY28E EPS i.e. three year average – one year forward price/earning, implying a potential upside of 24% from the current market price.

According to the brokerage Privi Speciality Chemicals is well-positioned for sustainable growth, supported by its relatively low crude-linked exposure (~25%), which provides resilience against ongoing energy market volatility and supports margin stability.

The upcoming mergers with Privi Fine Science, Privi BiotechnologiesL and PRIGIV, joint venture with Givauda are expected to expand its specialty aroma portfolio. Consequently, this is expected to drive revenue growth and enhance earnings.

Further, the company's expansion into high-value specialty molecules such as Maltol, Ethyl Maltol, and Cyclopentanone (from the Corn Cob route), coupled with backward integration into Furfural, is expected to contribute meaningfully to revenues while improving cost competitiveness and margins.

The brokerage expects Privi to clock a compound annual growth rate of 25%/27%/34% in revenue/Ebitda/PAT during FY26-28.

Motilal Oswal has reiterated its Buy rating on the stock. 

Click on the attachment to read the full report:

Motilal Oswal Privi Update.pdf
VIEW DOCUMENT

ALSO READ: TCS, Infosys, Wipro and More Cut to Sell'; IT Sector Underweight — Check Nirmal Bang's Latest Target Prices

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source
Loading PDF...